Effects of cysteine on the pharmacokinetics of tamoxifen in rats with protein-calorie malnutrition

References

• al-Shawi MK, Urbatsch IL, Senior AE. (1994). Covalent inhibitors of P-glycoprotein ATPase activity. J Biol Chem 269:8986–8992.
   PubMed Web of Science ®Google Scholar
• Bae SK, Lee SJ, Kwon JW, Kim WB, Lee MG. (2004). Effects of protein-calorie malnutrition on the pharmacokinetics of DA-7867, a new oxazolidinone, in rats. J Pharm Pharmacol 56:635–642.
   PubMed Web of Science ®Google Scholar
• Bradford MM. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254.
   PubMed Web of Science ®Google Scholar
• Cho MK, Kim YG, Lee MG, Kim SG. (1999). Suppression of rat hepatic cytochrome P450s by protein-calorie malnutrition: complete or partial restoration by cysteine or methionine supplementation. Arch Biochem Biophys 372:150–158.
   PubMed Web of Science ®Google Scholar
• Choi YH, Kim SG, Lee MG. (2006). Dose-independent pharmacokinetics of metformin in rats: Hepatic and gastrointestinal first-pass effects. J Pharm Sci 95:2543–2552.
   PubMed Web of Science ®Google Scholar
• Choi YH, Yoon I, Kim YG, Lee MG. (2012). Effects of cysteine on the pharmacokinetics of docetaxel in rats with protein-calorie malnutrition. Xenobiotica 42:442–455.
   PubMed Web of Science ®Google Scholar
• Chiou WL. (1978). Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level–time curve. J Pharmacokinet Biopharm 6:539–546.
   PubMedGoogle Scholar
• Chiou WL, Barve A. (1998). Linear correlation of the fraction of oral dose absorbed of 64 drugs between humans and rats. Pharm Res 15:1792–1795.
   PubMed Web of Science ®Google Scholar
• DeMario MD, Ratain MJ. (1998). Oral chemotherapy: rationale and future directions. J Clin Oncol 16:2557–2567.
   PubMed Web of Science ®Google Scholar
• Denke M, Wilson JD. (1998) Protein and energy malnutrition. In: Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo DL, (eds.). Principles of Internal Medicine. 14th edn. McGraw-Hill: New York, pp. 452–454.
   Google Scholar
• Duggleby RG. (1995). Analysis of enzyme progress curves by nonlinear regression. Meth Enzymol 249:61–90.
   PubMed Web of Science ®Google Scholar
• Emery MG. (2000) Chapter 38. Estrogens and progestins. In: Metabolic Drug Interactions. Levy RH, Thummel KE, Trager WF, Hansten PD, Eichelabaum M (Eds). Lippincott Williams & Wilkins. A Wolters Kluwet Company, Philadelphia. pp.551–528.
   Google Scholar
• Fagerholm U. (2007). Prediction of human pharmacokinetics–gastrointestinal absorption. J Pharm Pharmacol 59:905–916.
   PubMed Web of Science ®Google Scholar
• Föger F, Schmitz T, Bernkop-Schnürch A. (2006) In vivo evaluation of an oral delivery system for P-gp substrates based on thiolated chitosan. Biomaterials 27:4250–4255.
   PubMed Web of Science ®Google Scholar
• Gant TW, O’Connor CK, Corbitt R, Thorgeirsson U, Thorgeirsson SS. (1995). In vivo induction of liver P-glycoprotein expression by xenobiotics in monkeys. Toxicol Appl Pharmacol 133:269–276.
   PubMed Web of Science ®Google Scholar
• Gibaldi M, Perrier D. (1982) Pharmacokinetics, 2nd edn. Marcel–Dekker: New York.
   Google Scholar
• González-Hernández I, Jung-Cook H, Sotelo A. (2008). Effect of malnutrition on the pharmacokinetics of cefuroxime axetil in young rats. J Pharm Pharm Sci 11:9–21.
   PubMed Web of Science ®Google Scholar
• Hong H, Lu Y, Ji ZN, Liu GQ. (2006). Up-regulation of P-glycoprotein expression by glutathione depletion-induced oxidative stress in rat brain microvessel endothelial cells. J Neurochem 98:1465–1473.
   PubMed Web of Science ®Google Scholar
• Jacolot F, Simon I, Dreano Y, Beaune P, Riche C, Berthou F. (1991). Identification of the cytochrome P450 IIIA family as the enzymes involved in the N-demethylation of tamoxifen in human liver microsomes. Biochem Pharmacol 41:1911–1919.
   PubMed Web of Science ®Google Scholar
• Jordan VC. (1988). The development of tamoxifen for breast cancer therapy: a tribute to the late Arthur L. Walpole. Breast Cancer Res Treat 11:197–209.
   PubMed Web of Science ®Google Scholar
• Kaminsky LS, Zhang QY. (2003). The small intestine as a xenobiotic-metabolizing organ. Drug Metab Dispos 31:1520–1525.
   PubMed Web of Science ®Google Scholar
• Laperche Y, Preaux AM, Feldmann G, Mahu JL, Berthelot P. (1981). Effect of fasting on organic anion uptake by isolated rat liver cells. Hepatology 1:617–621.
   PubMedGoogle Scholar
• Lee JH, Suh OK, Lee MG. (2004). Pharmacokinetic changes in drugs during protein-calorie malnutrition: correlation between drug metabolism and hepatic microsomal cytochrome P450 isozymes. Arch Pharm Res 27:693–712.
   PubMed Web of Science ®Google Scholar
• Lee MG, Chiou WL. (1983). Evaluation of potential causes for the incomplete bioavailability of furosemide: gastric first-pass metabolism. J Pharmacokinet Biopharm 11:623–640.
   PubMedGoogle Scholar
• Lee YM, Song IS, Kim SG, Lee MG, Chung SJ, Shim CK. (2003). The suppressed expression and functional activity of hepatic P-glycoprotein in rats with protein-calorie malnutrition. J Pharm Sci 92:1323–1330.
   PubMed Web of Science ®Google Scholar
• Lewis DFV. (1996) P450 Substrate specificity and metabolism. In: Lewis DFV (Ed). Cytochromes P450 structure, function and mechanism. Taylor & Francis: Bristol, p. 123.
   Google Scholar
• Lowry SF, Goodgame JT Jr, Norton JA, Jones DC, Brennan MF. (1977). Effect of protein malnutrition on host-tumor composition and growth. Surg Forum 28:143–145.
   PubMedGoogle Scholar
• Martignoni M, Groothuis G, de Kanter R. (2006). Comparison of mouse and rat cytochrome P450-mediated metabolism in liver and intestine. Drug Metab Dispos 34:1047–1054.
   PubMed Web of Science ®Google Scholar
• Nitenberg G, Raynard B. (2000). Nutritional support of the cancer patient: issues and dilemmas. Crit Rev Oncol Hematol 34:137–168.
   PubMed Web of Science ®Google Scholar
• Piao Y, Shin SC, Choi JS. (2008). Effects of oral kaempferol on the pharmacokinetics of tamoxifen and one of its metabolites, 4-hydroxytamoxifen, after oral administration of tamoxifen to rats. Biopharm Drug Dispos 29:245–249.
   PubMed Web of Science ®Google Scholar
• Rémésy C, Demigné C. (1983). Changes in availability of glucogenic and ketogenic substrates and liver metabolism in fed or starved rats. Ann Nutr Metab 27:57–70.
   PubMed Web of Science ®Google Scholar
• Riley J, Styles J, Verschoyle RD, Stanley LA, White IN, Gant TW. (2000). Association of tamoxifen biliary excretion rate with prior tamoxifen exposure and increased mdr1b expression. Biochem Pharmacol 60:233–239.
   PubMed Web of Science ®Google Scholar
• Soucek P, Gut I. (1992). Cytochromes P-450 in rats: structures, functions, properties and relevant human forms. Xenobiotica 22:83–103.
   PubMed Web of Science ®Google Scholar
• Stephens RH, O’Neill CA, Warhurst A, Carlson GL, Rowland M, Warhurst G. (2001). Kinetic profiling of P-glycoprotein-mediated drug efflux in rat and human intestinal epithelia. J Pharmacol Exp Ther 296:584–591.
   PubMed Web of Science ®Google Scholar
• Suh JH, Kang HE, Yoon IS, Yang SH, Kim SH, Lee HJ, Shim CK, Lee MG. (2011). Cysteine effects on the pharmacokinetics of etoposide in protein-calorie malnutrition rats: increased gastrointestinal absorption by cysteine. Xenobiotica 41:885–894.
   PubMed Web of Science ®Google Scholar
• Teft WA, Mansell SE, Kim RB. (2010) Endotoxin, the active metabolite of tamoxifen, is a substrate of the efflux transporter P-glycoprotein (MDR1). Drug Dispos Metab 39:558–562.
   PubMedGoogle Scholar
• Troutman MD, Thakker DR. (2003). Novel experimental parameters to quantify the modulation of absorptive and secretory transport of compounds by P-glycoprotein in cell culture models of intestinal epithelium. Pharm Res 20:1210–1224.
   PubMed Web of Science ®Google Scholar
• Turgeon D, Carrier JS, Lévesque E, Hum DW, Bélanger A. (2001). Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members. Endocrinology 142:778–787.
   PubMed Web of Science ®Google Scholar
• van Waterschoot RA, Lagas JS, Wagenaar E, van der Kruijssen CM, van Herwaarden AE, Song JY, Rooswinkel RW, van Tellingen O, Rosing H, Beijnen JH, Schinkel AH. (2009). Absence of both cytochrome P450 3A and P-glycoprotein dramatically increases docetaxel oral bioavailability and risk of intestinal toxicity. Cancer Res 69:8996–9002.
   PubMed Web of Science ®Google Scholar
• Varma MV, Panchagnula R. (2005). Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo. Eur J Pharm Sci 25:445–453.
   PubMed Web of Science ®Google Scholar
• Yang SH, Suh JH, Lee MG. (2010). Pharmacokinetic interaction between tamoxifen and ondansetron in rats: non-competitive (hepatic) and competitive (intestinal) inhibition of tamoxifen metabolism by ondansetron via CYP2D subfamily and 3A1/2. Cancer Chemother Pharmacol 65:407–418.
   PubMedGoogle Scholar
• Wacher VJ, Wu CY, Benet LZ. (1995). Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy. Mol Carcinog 13:129–134.
   PubMed Web of Science ®Google Scholar
• Walker O, Dawodu AH, Salako LA, Alván G, Johnson AO. (1987). Single dose disposition of chloroquine in kwashiorkor and normal children–evidence for decreased absorption in kwashiorkor. Br J Clin Pharmacol 23:467–472.
   PubMed Web of Science ®Google Scholar
• Werle M, Hoffer M. (2006). Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine. J Control Release 111:41–46.
   PubMed Web of Science ®Google Scholar
• Wilkinson GR, Shand DG. (1975). Commentary: a physiological approach to hepatic drug clearance. Clin Pharmacol Ther 18:377–390.
   PubMed Web of Science ®Google Scholar